XML 36 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
EQUITY AWARDS (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

A summary of stock option activity in the Plan during the three months ended March 31, 2024 and 2023 follows:

Three Months Ended March 31, 2024

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

465,680

 

 

$

28.12

 

 

 

5.46

 

 

$

2,782

 

Granted

 

 

2,500

 

 

 

30.49

 

 

 

 

 

 

 

Exercised

 

 

(3,300

)

 

 

20.91

 

 

 

 

 

 

 

Forfeited

 

 

(10,500

)

 

 

34.84

 

 

 

 

 

 

 

Balance, March 31, 2024

 

 

454,380

 

 

$

28.03

 

 

 

5.20

 

 

$

1,632

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

294,880

 

 

$

26.28

 

 

 

3.77

 

 

$

1,378

 

 

Three Months Ended March 31, 2023

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

497,820

 

 

$

28.07

 

 

 

5.87

 

 

$

3,402

 

Granted

 

 

15,500

 

 

 

29.91

 

 

 

 

 

 

 

Exercised

 

 

(8,800

)

 

 

25.57

 

 

 

 

 

 

 

Forfeited

 

 

(15,440

)

 

 

30.42

 

 

 

 

 

 

 

Balance, March 31, 2023

 

 

489,080

 

 

$

28.10

 

 

 

5.77

 

 

$

1,037

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

281,500

 

 

$

25.57

 

 

 

4.26

 

 

$

850

 

Schedule of Nonvested Stock Option Activity

A summary of nonvested stock option activity in the Plan during the three months ended March 31, 2024 and 2023 follows:

Three Months Ended March 31, 2024

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

182,570

 

 

$

6.10

 

Granted

 

 

2,500

 

 

 

5.28

 

Vested

 

 

(17,170

)

 

 

5.53

 

Forfeited

 

 

(8,400

)

 

 

8.95

 

Balance, March 31, 2024

 

 

159,500

 

 

$

6.09

 

 

Three Months Ended March 31, 2023

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

216,480

 

 

$

5.95

 

Granted

 

 

15,500

 

 

 

6.02

 

Vested

 

 

(18,200

)

 

 

5.62

 

Forfeited

 

 

(6,200

)

 

 

13.10

 

Balance, March 31, 2023

 

 

207,580

 

 

$

5.99

 

Plan Information

Information related to stock options in the Plan is as follows for the three months ended:

 

 

March 31, 2024

 

 

March 31, 2023

 

Intrinsic value of options exercised

 

$

31

 

 

$

22

 

Cash received from options exercised

 

 

69

 

 

 

225

 

Weighted average fair value of options granted

 

 

5.28

 

 

 

6.02

 

 

Summary of Restricted Stock Awards and Units Activity

A summary of restricted stock activity in the Plan during the three months ended March 31, 2024 and 2023 follows:

Three Months Ended March 31, 2024

 

Number of
Shares

 

 

Weighted-Average
 Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

15,390

 

 

$

28.87

 

Granted

 

 

2,388

 

 

 

30.49

 

Vested

 

 

(3,511

)

 

 

5.31

 

Forfeited

 

 

(221

)

 

 

34.10

 

Balance, March 31, 2024

 

 

14,046

 

 

$

29.14

 

Three Months Ended March 31, 2023

 

Number of
Shares

 

 

Weighted-Average
Grant
 Date Fair Value

 

Outstanding at beginning of year

 

 

18,930

 

 

$

27.51

 

Granted

 

 

1,474

 

 

 

34.10

 

Vested

 

 

(2,970

)

 

 

27.50

 

Forfeited

 

 

(880

)

 

 

27.78

 

Balance, March 31, 2023

 

 

16,554

 

 

$

29.03